“Dedication, purpose, impact, world-leading science”—those are some of the reasons people want to work at this biotech firm, which aims to combat a range of diseases and has four FDA-approved drugs. In a “world driven by the dollar,” says one employee, it’s “refreshing” to be at a company where the “bottom line is with patients.”
Learn more in the Great Place to Work review here.
News about Regeneron Pharmaceuticals
Scientists are ready to move an experimental treatment into phase 1 trials.
“We should only be working on two things, health and the freaking environment.”
But Dupixent's high cost could be a problem.
They say a robust review process is needed to convince doctors and insurers new drugs have value.